在非心脏外科手术中用于术后心脏保护的药理学药物
Waynice Neiva de Paula-Garcia1, Stefan De Hert2
1Department of Anaesthesiology, AC Camargo Cancer Center, São Paulo, Brazil.
Current opinion in anaesthesiology
|April 17, 2025
概括
目前对外科手术期间心肌梗塞的药理学策略正在发展. 虽然β抑制剂可以减少心脏事件,但针对RAAS抑制剂和他类药物等药物的个性化方法是优化高风险手术患者结果的关键.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 外科手术期间的心肌梗塞是手术患者的一个重大问题.
- 现有的药理管理指南正在根据新的证据进行重新评估.
研究的目的:
- 审查当前的药理学策略,以减轻外科手术期间心肌损伤.
- 介绍干预措施的好处和危害,并确定知识差距.
主要方法:
- 系统审查有关术后心脏药物的现有文献.
- 分析临床试验数据和指导方针建议.
主要成果:
- β抑制剂可以减少主要的不良心脏事件,但不适当的启动是有害的.
- 继续使用雷宁-氨-阿尔多斯特系统 (RAAS) 抑制剂可能是安全的.
- 由于其热作用,他类药物仍然至关重要;阿司匹林的持续使用取决于出血风险.
- 术内血压控制策略和术后心肌损伤治疗强化需要进一步研究.
结论:
- 新的数据支持对外科手术期间药物管理的个性化方法.
- 未来的研究应该专注于风险分层,优化药物策略,并为高风险的手术群体开发新型疗法.
相关概念视频
Heart Failure Drugs: Inotropic Agents
414
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
414
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
315
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
315
Heart Failure Drugs: β-Blockers
271
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
271
Antianginal Drugs: Nitrates and β-Blockers
442
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
442
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
648
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
648
Parenteral Anesthetics: Overview
84
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
84


